Modern imaging modalities are increasingly playing a role in planning therapy for aortic diseases and in follow-up exams after surgery or endovascular intervention. The methods employed for minimally invasive endovascular therapy have been continually improved in recent years and are now being used by vascular surgeons or radiologists to treat thoracic, thoracoabdominal and abdominal aortic…
In the Caucasian population, subarachnoid hemorrhage (SAH) due to a ruptured intracranial aneurysm is seen with an incidence of 6 to 8 per 100,000. In some specific countries such as Finland and Japan these numbers rise to 20 per 100,000. 60% of patients presenting with an aneurysmal SAH are female. The presenting symptoms are: thunderclap headache in combination with (temporary) loss of…
For the first time in 33 years, wound healing was the focus of a dedicated session at the 33rd annual VEITHsymposium for vascular surgeons in New York (11/06). This underscores the fact that wound healing is heading increasingly towards a speciality that warrants the special attention of dedicated people willing to embrace an interdisciplinary approach to non-healing or complex wounds.
Using the different shaped tips of ARC 350L and TissueSeal or Ligator instruments, made by Bowa, surgeons can permanently seal large veins, arteries or bunched tissue. All of these special tools gained a red dot award for ergonomics and practicality.
Already in 1993, the world market for contrast media was thought to be worth $ 3 billion. In 2001, an astonishing 12.2 million contrast medium-supported CT studies were carried out in Europe alone. Currently, the overall sales of contrast media are estimated to rise to $ 915 million in Europe in 2008.
Gadofosveset trisodium (trade name: Vasovist) is the first approved blood pool contrast agent worldwide for the diagnosis of vascular disease, Bayer Schering Pharma AG reports.
Bracco Imaging announces that the MR Angiography indication for MultiHance has been approved by the EU member states via a mutual recognition procedure. MultiHance is a gadolinium based contrast agent that is characterized by high relaxivity and dual route of excretion.
Endovascular brachytherapy has been successfully modified by scientists at Isotopen Technologie München AG (ITM), solving problems of radiation exposure to Rhenium-188. The researchers are now producing Rhenium-188 with previously unknown high specific activity in a new type of generator, Isotopen Technologie reports.
'Alles im Fluss' is the slogan of the 22nd Annual Congress of the German Society for Endovascular & Vascular Surgery, to be held from 6-9 September, in Muelheim an der Ruhr.
Scientific meetings held since 1998 at Alpbach, Germany, have attracted the sponsorship of leading associations and companies such as the Philip Morris External Research Programme, the Donors Association of German Science, Swiss National Fund, the German Heart Centre Foundation, Berlin, and Philips Medical Systems. At the 4th Alpbach Meeting, which focused on Magnetic Resonance, Contrast…
Vascular experts urge caution over stent lacement to prevent stroke.
Tissue engineering caused a stir at the 34th Annual Meeting of the Germany Society for Thoracic and Cardiovascular Surgery.
Germany - Following positive results in numerous animal studies and the first human implantations of the Biontronik Absorbable Metal Stent (AMS) in below-the-knee arteries that confirmed device safety, at the end of July the first patients (worldwide) received AMS implants.
France - Four studies of three TAXUS paclitaxel-eluting stents have demonstrated their safety and efficacy, according to the maker, Boston Scientific Corporation of Natick, Maryland, USA.
